fbpx
Sign up now!
Don't show this again
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
PORK POULTRY
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

.

MetaStim®: The best balance of humoral, cellular immunity

An interview with
Dennis Foss, DVM, PhD
Research Director
Zoetis Global Biologicals Swine 

 

Download the pdf

Q: What’s the purpose of an adjuvant?

DF: Adjuvants are the instruction manual for the immune system. They play an important role in determining the type of immunity activated. When properly paired with vaccines, adjuvants can steer the animal’s response toward the best, most effective type of immunity for a given pathogen.

 

Q: MetaStim® is the adjuvant in Fostera Gold® PCV MH, which is for healthy pigs 3 days of age or older against porcine circovirus type 2 (PCV2) as well as respiratory disease due to Mycoplasma hyopneumoniae (M. hyo). Why MetaStim?

DF: We evaluated several adjuvants. MetaStim provided the best combination of humoral and cellular immunity against PCV2.1 There are other advantages. MetaStim is an oil-in-water emulsion with an oil content of less than 1% by volume. It provides a strong immune response, but there’s minimal reactivity.2 Injection site reactions are rare and negligible, which was demonstrated in a large three-state field trial with Fostera Gold PCV MH.3

MetaStim is also responsible for the vaccine’s long duration of immunity (DOI), which is 23 weeks for PCV2. That’s longer than the DOI for any other PCV2 vaccine in the US, which contain different adjuvants. The DOI is 23 weeks for M. hyo as well.

 

Q: How do humoral and cellular immunity differ?

DF: Humoral means body fluids. Humoral immunity involves the release of pathogen- fighting antibodies into serum or fluid. Cellular immunity happens by direct action of a cell — T lymphocytes destroy cells that are infected. Both types of immunity are important.

 

Q: Tell us more about why both types of immunity are important.

DF: Humoral immunity can be very effective at preventing the initial entry of a virus at the mucosal surface. It can neutralize virus in blood. Antibodies, however, can’t get to a virus once it’s in a cell — and that’s where cell-mediated immunity comes in.

I’ll use PCV2 again as an example. It’s a persistent virus that can hide out in some cells, such as macrophages, and then spread, usually to lymph nodes. Ultimately, the virus replicates in lymphocytes and kills them, causing immune suppression. The pig is left susceptible to other infectious diseases.

Activating both humoral and cellular immunity provides a double whammy against PCV2. There is evidence that M. hyo can also persist in cells,4 which is one more reason why we chose MetaStim for the adjuvant in Fostera Gold PCV MH.

 

Q: Don’t other adjuvants stimulate both types of immunity?

DF:Most do but the relative amounts of each type of immune response vary. Vaccines with a high mineral oil content may induce a higher immediate antibody response but less cellular immunity. The goal of adjuvant selection is to induce the best balance of humoral and cellular immunity for a given pathogen. We found MetaStim to be the best choice for use in Fostera Gold PCV MH.

 

Q: What evidence is there MetaStim induces both humoral and cellular immunity in pigs?

DF: This is something we’ve studied extensively. When MetaStim was used as the adjuvant for the PCV2a/PCV2b/M. hyo combination in Fostera Gold PCV MH, there were high antibody titers following two doses of vaccine. Even in pigs that received only one dose of vaccine, there was a rapid PCV2 antibody response in challenged pigs. This indicates a robust priming of the humoral immune response with a single dose of vaccine. In addition, the cellular response was significantly higher compared to the response after two doses of a PCV2 vaccine with a different adjuvant (Figure 1).5

* Vaccination induced a biologically relevant CMI response if specific IFNg (interferon gamma) secretion was above 50 SFC/10e6 PBMC. Post-challenge, PCV2-specific T cells move into the tissues and out of the blood to protect against PCV2 infection. [CLICK ON FIGURE TO ENLARGE]

Q: But do your experimental studies with MetaStim translate into success in the field?

DF: They do. One of several studies involved more than 880 pigs on a Midwest farm.6 Pigs were vaccinated with Fostera Gold PCV MH or with other commercial PCV2 plus M. hyo vaccines. Then we challenged pigs with PCV2d, the most prevalent PCV2 genotype in US herds, as well as M. hyo. Pigs that received Fostera Gold PCV MH had significantly less (p < 0.05) PCV2 viremia than unvaccinated controls, and they had fewer lung lesions and higher final weights than pigs that received the other PCV2/M. hyo vaccines.7

 

Q: What do you most want pork producers and veterinarians to know about MetaStim?

DF: That in the course of our PCV2 research program, we have extensively tested a wide variety of adjuvants, including current and experimental formulations. We have yet to find an adjuvant that outperforms MetaStim’s safety and efficacy in PCV2 challenge studies.


All trademarks are the property of Zoetis Services LLC or a related company  or a licensor unless otherwise noted. 

 

1 Data on file, Study Report No. B820R-US17-747, Zoetis LLC.
2 Data on file, Study Report No. B921R-US16-609, Zoetis LLC.
3 Ibid.
4 Raymond BBA, et al. Mycoplasma hyopneumoniae resides intracellularly within porcine epithelial cells. Sci Rep. 2018;8:17697.
5 Data on file, Study Report No. B820R- US-17-747, Zoetis LLC.
6 Data on file, Study Report No. 16 PRGBIO-01-01, Zoetis LLC.
7 Ibid
.

TOOLBOX, Issue 17
Toolbox is a series of interviews with veterinarians about their experiences managing antimicrobials, vaccines and other tools for swine health. It is produced by the editors of Pig Health Today® on behalf of the US Pork Business of Zoetis.
FSTRA-00187
February 2020



Posted on February 21, 2020

tags: , , ,
RELATED NEWS



You must be logged in to edit your profile.

Share It
E. coli has been a severe disease in the pork industry for decades and continues to be prevalent, especially during the post-weaning period when maternal antibodies aren’t available to stop severe diarrhea. How can we tackle this problem?

Click an icon to share this information with your industry contacts.
Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.